493 related articles for article (PubMed ID: 3891786)
1. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
[TBL] [Abstract][Full Text] [Related]
2. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
3. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
Popp DA; Shah SD; Cryer PE
J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
[TBL] [Abstract][Full Text] [Related]
4. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
Staten MA; Matthews DE; Cryer PE; Bier DM
Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
[TBL] [Abstract][Full Text] [Related]
5. Glycemic actions of alanine and terbutaline in IDDM.
Wiethop BV; Cryer PE
Diabetes Care; 1993 Aug; 16(8):1124-30. PubMed ID: 8375242
[TBL] [Abstract][Full Text] [Related]
6. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
[TBL] [Abstract][Full Text] [Related]
7. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.
Avogaro A; Valerio A; Gnudi L; Maran A; Miola M; Duner E; Marescotti C; Iori E; Tiengo A; Nosadini R
Diabetologia; 1992 Feb; 35(2):129-38. PubMed ID: 1547916
[TBL] [Abstract][Full Text] [Related]
8. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
Rattarasarn C; Dagogo-Jack S; Zachwieja JJ; Cryer PE
Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
[TBL] [Abstract][Full Text] [Related]
10. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
11. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia.
Enoksson S; Caprio SK; Rife F; Shulman GI; Tamborlane WV; Sherwin RS
J Clin Endocrinol Metab; 2003 Apr; 88(4):1503-11. PubMed ID: 12679430
[TBL] [Abstract][Full Text] [Related]
12. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
13. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
14. Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects.
Avogaro A; Gnudi L; Valerio A; Maran A; Miola M; Opportuno A; Tiengo A; Bier DM
J Clin Endocrinol Metab; 1993 Apr; 76(4):845-50. PubMed ID: 8473394
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.
Tse TF; Clutter WE; Shah SD; Miller JP; Cryer PE
J Clin Invest; 1983 Jul; 72(1):270-7. PubMed ID: 6409929
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
Kinsley BT; Simonson DC
J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
[TBL] [Abstract][Full Text] [Related]
17. Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans.
Divertie GD; Jensen MD; Cryer PE; Miles JM
Am J Physiol; 1997 Jun; 272(6 Pt 1):E1130-5. PubMed ID: 9227461
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
Dagogo-Jack SE; Craft S; Cryer PE
J Clin Invest; 1993 Mar; 91(3):819-28. PubMed ID: 8450063
[TBL] [Abstract][Full Text] [Related]
19. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.
Schwartz NS; Clutter WE; Shah SD; Cryer PE
J Clin Invest; 1987 Mar; 79(3):777-81. PubMed ID: 3546378
[TBL] [Abstract][Full Text] [Related]
20. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
